A seroepidemiologic profile of persons seeking anonymous HIV testing at alternate sites in upstate New York

  • John C. Grabau
  • Benedict I. Truman
  • Dale L. Morse


Alternate sites for human immunodeficiency virus (HIV) counseling and testing were established in New York State in the late summer of 1985. In a six-month period at the beginning of 1986, 14.4% of individuals who received HIV test results were seropositive. Questionnaire data were obtained from 1,635 persons for development of an epidemiologic profile of attendees: most were white (83%), males (72%), born in the United States (94%), well (80%), who sought testing because they had risk factors (73%) or had had sex with persons at risk (26%). Higher rates of HIV seropositive were found among blacks (26%), Hispanics (30%), males (16%), and those with a known risk factor (18%), and among those with symptoms (21%), than among those without these characteristics. Factors associated with HIV seropositivity are described.


Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Human Immunodeficiency Virus Test Intravenous Drug User Alternate Site 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Koop CE: Surgeon General’s Report on Acquired Immune Deficiency Syndrome. Washington DC, Public Health Service, US Department of Health and Human Services, October 1986.Google Scholar
  2. 2.
    Division of Sexually Transmitted Diseases, Center for Preventive Services, Centers for Disease Control: Human T-lymphotrophic virus type III/lymphade-nopathy-associated virus antibody testing at alternate sites. MMWR 1986;35:284–287.Google Scholar
  3. 3.
    Hopkins RS: Results of antibody testing at community-based AIDS prevention centers. West Virginia EPI-LOG 1986; 7:1–3.Google Scholar
  4. 4.
    Henry K, Brown RJ, Polesky HF, et al: Nondonor HIV antibody testing in Minnesota. N Engl J Med 1986; 315:581–582.PubMedCrossRefGoogle Scholar
  5. 5.
    Holston JL: Testing for HTLV-III/LAV antibody. Ala J Med Sci 1986;23:269–271.PubMedGoogle Scholar
  6. 6.
    AIDS Weekly Surveillance Report—United States, Public Health Service, Centers for Disease Control, Department of Health and Human Services, October 15, 1987.Google Scholar
  7. 7.
    New York State Department of Health, AIDS Surveillance Monthly Update, March 1986.Google Scholar
  8. 8.
    Zuck TF: Greetings—with comments on lessons learned this past year from HIV antibody testing and from counseling blood donors [editorial]. Transfusion 1986; 26:493.PubMedCrossRefGoogle Scholar
  9. 9.
    Center for Drugs and Biologies, US Food and Drug Administration; AIDS Branch, Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control: Update: Revised Public Health Service definition of persons who should refrain from donating blood and plasma—United States. MMWR 1985;34:547–548.Google Scholar
  10. 10.
    Des Jarlais DC, Wish E, Friedman SR. et al: Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus: Current trends in New York City. NY State J Med 1987; 87:283–286.Google Scholar

Copyright information

© Medical Society of the State of New York 1989

Authors and Affiliations

  • John C. Grabau
    • 1
  • Benedict I. Truman
    • 2
  • Dale L. Morse
    • 2
  1. 1.the AIDS InstituteNew York State Department of HealthAlbanyUSA
  2. 2.the Bureau of Communicable Disease ControlNew York State Department of HealthAlbanyUSA

Personalised recommendations